{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:17:00Z","timestamp":1786987020609,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.clml.2020.04.011","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T02:25:46Z","timestamp":1587435946000},"page":"e529-e541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outcome of Childhood Acute Myeloid Leukemia With FLT3-ITD Mutation: The Experience of Children\u2019s Cancer Hospital Egypt, 2007-17"],"prefix":"10.1016","volume":"20","author":[{"given":"Samah Fathy","family":"Semary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1677-0360","authenticated-orcid":false,"given":"Mahmoud","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Yassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Albeltagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4795-2167","authenticated-orcid":false,"given":"Nayera","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.04.011_bib1","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1182\/blood-2012-02-392506","article-title":"How I treat pediatric acute myeloid leukemia","volume":"119","author":"Rubnitz","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bjh.12947","article-title":"How I treat paediatric relapsed acute myeloid leukaemia","volume":"166","author":"Kaspers","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.04.011_bib3","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood.V80.10.2584.2584","article-title":"Expression of the FMS\/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages","volume":"80","author":"Birg","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib4","first-page":"1911","article-title":"Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia","volume":"10","author":"Nakao","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.04.011_bib5","first-page":"190","article-title":"FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group","volume":"111","author":"Abu-Duhier","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.04.011_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/(SICI)1096-911X(199912)33:6<525::AID-MPO1>3.0.CO;2-8","article-title":"Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia","volume":"33","author":"Kondo","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.clml.2020.04.011_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1182\/blood.V97.1.89","article-title":"Prevalence and prognostic significance of FLT3 internal tandem duplication in pediatric acute myeloid leukemia","volume":"97","author":"Meshinchi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12185-017-2395-x","article-title":"Risk-stratified therapy for children with FLT3-ITD\u2013positive acute myeloid leukemia: results from the JPLSG AML-05 study","volume":"107","author":"Shimada","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2020.04.011_bib9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.bbmt.2011.02.003","article-title":"Role of allogeneic transplantation for FLT3\/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed\u00a0patients from a single institution","volume":"17","author":"DeZern","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2020.04.011_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ajh.24140","article-title":"Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade","volume":"90","author":"Badar","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.04.011_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/bmt.2015.170","article-title":"FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML","volume":"51","author":"Song","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.04.011_bib12","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood-2006-03-009233","article-title":"Clinical implications of FLT3 mutations in pediatric AML","volume":"108","author":"Meshinchi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib14","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","article-title":"The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United King","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11899-010-0060-z","article-title":"Prognostic factors in pediatric acute myeloid leukemia","volume":"5","author":"Radhi","year":"2010","journal-title":"Curr Hematol Malign Rep"},{"key":"10.1016\/j.clml.2020.04.011_bib16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1182\/blood-2012-02-408336","article-title":"Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children\u2019s Oncology Group","volume":"120","author":"Loken","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.moh.0000148760.15412.df","article-title":"Prognostic factors in acute myeloid leukemia","volume":"12","author":"Avivi","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.clml.2020.04.011_bib18","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1182\/blood-2011-05-353185","article-title":"Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia","volume":"118","author":"Staffas","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib19","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2014-10-605808","article-title":"Secondary mutations as mediators of resistance to targeted therapy in leukemia","volume":"125","author":"Daver","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib20","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1182\/blood-2014-05-578070","article-title":"Differential impact of allelic ratio and insertion site in FLT3-ITD\u2013positive AML with respect to allogeneic transplantation","volume":"124","author":"Schlenk","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib21","first-page":"17","article-title":"Internal tandem duplication of FLT3 gene in Egyptian pediatric acute myeloid leukemia and acute lymphoblastic leukemia","volume":"15","author":"Dina Yassin","year":"2003","journal-title":"J\u00a0Egypt Natl Canc Inst"},{"key":"10.1016\/j.clml.2020.04.011_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1751-553X.2008.01039.x","article-title":"Prognostic significance of foetal-like tyrosine kinase 3 mutation in Egyptian children with acute leukaemia","volume":"31","author":"Al-Tonbary","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.clml.2020.04.011_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/07357900903095649","article-title":"Analysis of FLT3-ITD and FLT3-Asp835 mutations in de novo acute myeloid leukemia: evaluation of incidence, distribution pattern, correlation with cytogenetics and characterization of internal tandem duplication from Indian population","volume":"28","author":"Ahmad","year":"2010","journal-title":"Cancer Invest"},{"key":"10.1016\/j.clml.2020.04.011_bib24","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1182\/blood-2002-12-3627","article-title":"FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance","volume":"102","author":"Zwaan","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5045\/kjh.2011.46.2.88","article-title":"Prognostic significance of the FLT3 ITD mutation in patients with normal-karyotype acute myeloid leukemia in relapse","volume":"46","author":"Park","year":"2011","journal-title":"Korean J Hematol"},{"key":"10.1016\/j.clml.2020.04.011_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2141.2000.01831.x","article-title":"Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells","volume":"108","author":"Fenski","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.04.011_bib27","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3324\/haematol.2011.040592","article-title":"Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD","volume":"96","author":"de Jonge","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.04.011_bib28","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2008-01-117770","article-title":"Structural and numerical variation of FLT3\/ITD in pediatric AML","volume":"111","author":"Meshinchi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib29","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/1078-0432.CCR-04-1552","article-title":"Risk assessment in patients with acute myeloid leukemia and a normal karyotype","volume":"11","author":"Bienz","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2020.04.011_bib30","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib31","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/cncr.25670","article-title":"Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia","volume":"117","author":"Santos","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.04.011_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1309\/5DGB59KQA527PD47","article-title":"Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of FLT3 gene mutations","volume":"122","author":"Oyarzo","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2020.04.011_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood-2012-05-431486","article-title":"Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German\u2013Austrian AML Study Group (AMLSG)","volume":"121","author":"Paschka","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib34","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2006-04-015826","article-title":"FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia","volume":"110","author":"Mead","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-019-0127-z","article-title":"Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia","volume":"8","author":"Niparuck","year":"2019","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.clml.2020.04.011_bib36","first-page":"58","article-title":"FLT-3\/ITD mutation in pediatric leukemia and its clinical significance","volume":"26","author":"Wang","year":"2007","journal-title":"Ai Zheng"},{"key":"10.1016\/j.clml.2020.04.011_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4137\/CMPed.S16413","article-title":"Factors associated with delayed cancer diagnosis in Egyptian children","volume":"8","author":"Abdelkhalek","year":"2014","journal-title":"Clin Med Insights Pediatr"},{"key":"10.1016\/j.clml.2020.04.011_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MPH.0000000000001408","article-title":"Early deaths in pediatric acute leukemia: a major challenge in developing countries","volume":"41","author":"Hafez","year":"2019","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2020.04.011_bib39","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood-2005-03-1323","article-title":"No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRCAML10 and 12 trials","volume":"106","author":"Gale","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.04.011_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1200\/JCO.2012.43.7384","article-title":"Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group","volume":"31","author":"Kaspers","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.04.011_bib41","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/sj.leu.2401141","article-title":"Duration of first remission predicts remission rates and long-term survival\u00a0in\u00a0children with relapsed acute myelogenous leukemia","volume":"12","author":"Stahnke","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.04.011_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/cncr.22385","article-title":"Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia","volume":"109","author":"Rubnib","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.04.011_bib43","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1002\/cncr.30140","article-title":"Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis","volume":"122","author":"Deol","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.04.011_bib44","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/pbc.25437","article-title":"Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3\/ITD acute myeloid leukemia","volume":"62","author":"Tarlock","year":"2015","journal-title":"Pediatr Blood Cancer"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020301890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020301890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:33:46Z","timestamp":1761870826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020301890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2152265020301890"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.04.011","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of Childhood Acute Myeloid Leukemia With FLT3-ITD Mutation: The Experience of Children\u2019s Cancer Hospital Egypt, 2007-17","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}